Gara Jalqabaatti › Kansarii Prostate › Oregon › Portland
Qorannoo klinikaalii Kansarii Prostate Portland, OR keessatti
Qorannoo 33 Kansarii Prostate f Portland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- Oregon Health & Science University (OHSU), Portland
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Namoota walitti qabaa jiraSadarkaa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · Miili 12 fagaatti
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Namoota walitti qabaa jiraSadarkaa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Namoota walitti qabaa jiraSadarkaa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Namoota walitti qabaa jiraSadarkaa 4
- Oregon Health & Science University, Portland
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Oregon Health And Science University, Portland
Precision-Based Genomics in Prostate Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Oregon Health Sciences University, Portland
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Namoota walitti qabaa jiraSadarkaa 1
- Providence Portland Medical Center, Portland
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Namoota walitti qabaa jiraSadarkaa 2
- VA Portland Health Care System, Portland, OR, Portland
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- VA Portland Health Care System, Portland, OR, Portland
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Namoota walitti qabaa jiraSadarkaa 3
- VA Portland Health Care System ( Site 0038), Portland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Kaiser Permanente Northwest, Portland
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Namoota walitti qabaa jira
- Oregon Health & Science University, Portland
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Oregon Health & Science University, Portland
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Portland
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Portland
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Namoota walitti qabaa jiraSadarkaa 2
- VA Portland Health Care System, Portland, OR, Portland
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Namoota walitti qabaa jiraSadarkaa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- fi 1 dabalataa
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Oregon Health and Science University, Portland
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Namoota walitti qabaa jiraSadarkaa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- fi 1 dabalataa
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Oregon Health & Science University, Portland
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Namoota walitti qabaa jiraSadarkaa 2
- VA Portland Health Care System, Portland
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Oregon Health & Science University Hospital, Portland
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- OHSU Knight Cancer Institute, Portland
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Portland
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Namoota walitti qabaa jira
- OHSU Knight Cancer Institute, Portland
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
Namoota walitti qabaa jira
- OHSU Knight Cancer Institute, Portland
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Namoota walitti qabaa jiraSadarkaa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- fi 1 dabalataa
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Oregon Health Sciences University, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Portland
EMBRACE: Exercising Together
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
- OHSU Knight Cancer Institute, Portland
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- VA Portland Healthcare System, Portland
Qorannoo Kansarii Prostate magaalota biroo keessatti
- New York City, NYQorannoo 103
- Houston, TXQorannoo 76
- Los Angeles, CAQorannoo 61
- Boston, MAQorannoo 59
- St. Louis, MOQorannoo 46
- Chicago, ILQorannoo 45
- San Francisco, CAQorannoo 45
- Philadelphia, PAQorannoo 44
- Baltimore, MDQorannoo 43
- Nashville, TNQorannoo 42
- Seattle, WAQorannoo 42
- Washington, DCQorannoo 38
Qorannoo biroo Portland keessatti
- Kansara Qara'a Non-Small CellQorannoo 46
- Saree (Gosoota Hunda)Qorannoo 34
- Saree OljooQorannoo 33
- Kansara MetastatikiiQorannoo 29
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Dhibee QaraQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 25
- Kansa EndometiriyaaliiQorannoo 24
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 19
- Kansarii PancreasQorannoo 19
- Cufama OnneeQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.